Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL -mutant renal carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL -mutant renal carcinoma cells

Published:2008-01-22 Issue:4 Volume:29 Page:696-703
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Chintalapudi Mastan R.,Markiewicz Margaret,Kose Nurgun,Dammai Vincent,Champion Kristen J.,Hoda Rana S.,Trojanowska Maria,Hsu Tien

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/29/4/696/14132225/bgn019.pdf

Reference40 articles.

1. Molecular basis of the VHL hereditary cancer syndrome;Kaelin;Nat. Rev. Cancer,2002

2. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer;Yang;N. Engl. J. Med.,2003

3. Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma;Reuter;World J. Urol.,2007

4. Anti-angiogenic therapy in renal cell cancer;Srinivasan;BJU Int.,2007

5. Phase 2 studies of sunitinib and AG013736 in patients with cytokine-refractory renal cell carcinoma;George;Clin. Cancer Res.,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?;Biomedicines;2024-02-07

2. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification;Aging;2023-11-21

3. Resistance to antiangiogenic treatments: A review;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022

4. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis;Cancer Biology & Medicine;2021-12-22

5. Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity;Trends in Cancer;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3